New Genetic Testing Drive Aims to Personalise Cancer Care in Kenya

A public‑private initiative has launched genetic testing services to improve personalised cancer treatment and screening. The programme, introduced at a Nairobi centre, focuses first on BRCA testing for breast and ovarian cancer risks, with plans to expand molecular diagnostics for other tumour types. Clinicians say access to genetic insights can help tailor therapies and inform preventive strategies for high‑risk families. Stakeholders called for subsidised testing, clinician training and updated treatment guidelines to ensure equitable access across income groups and counties. The campaign underscores a shift towards precision medicine, even as experts caution that infrastructure and data governance must keep pace with technological advances.